Related Experiment Video
Updated: Aug 9, 2026

Induction of Maternal Immune Activation in Mice at Mid-gestation Stage with Viral Mimic Poly(I:C)
Published on: March 25, 2016
The control of mumps in Israel
P E Slater1, E Anis, A Leventhal
1Department of Epidemiology, Ministry of Health, Jerusalem, Israel.
Background:
Measles-mumps-rubella (MMR) vaccine replaced monovalent measles vaccine in the routine childhood vaccination schedule in Israel in December 1988, primarily to achieve the elimination of the congenital rubella syndrome. In this observational study, we report on changes in reported mumps incidence in Israel from the time of the introduction of MMR vaccine until the end of 1998.
Methods:
The report is based upon passive national surveillance of mumps incidence, which has been notifiable in Israel since 1977.
Results:
Reported mumps incidence in Israel is now less than 2% the pre-vaccine incidence.
Conclusions:
In the decade since the introduction of routine mumps vaccination in 1-year-olds in Israel, mumps control has been achieved. Although small outbreaks occur and may continue to occur in future years, because of under-vaccination of children, primary vaccine failure and waning immunity, it can tentatively be said that mumps is no longer a public health problem in Israel.
Insights
The introduction of the Measles-Mumps-Rubella (MMR) vaccine in Israel significantly reduced mumps incidence, achieving substantial disease control. Mumps is no longer considered a major public health concern in the region.
Area of Science:
- Epidemiology
- Vaccinology
- Public Health
Background:
- Measles-Mumps-Rubella (MMR) vaccine replaced monovalent measles vaccine in Israel in December 1988.
- The primary goal was to eliminate congenital rubella syndrome.
- This study examines mumps incidence changes post-MMR introduction.
Purpose of the Study:
- To assess the impact of MMR vaccine introduction on mumps incidence in Israel.
- To evaluate mumps control following a decade of routine vaccination.
Main Methods:
- Utilized passive national surveillance data for mumps incidence.
- Analyzed data from vaccine introduction (December 1988) through 1998.
- Mumps has been a notifiable disease in Israel since 1977.
Main Results:
- Reported mumps incidence decreased to less than 2% of pre-vaccine levels.
- Significant reduction in mumps cases observed over the decade.
Conclusions:
- Routine mumps vaccination in 1-year-olds has successfully controlled the disease in Israel.
- While small outbreaks may persist due to factors like under-vaccination, primary vaccine failure, and waning immunity, mumps is no longer a significant public health problem.
More Related Videos
Related Concept Videos
Vaccinations
Smallpox
Chickenpox
Poliomyelitis
Respiratory Syncytial Virus Disease
Malaria

